Connection

Athimalaipet Ramanan to Adolescent

Back to Details
This is a "connection" page, showing publications Athimalaipet Ramanan has written about Adolescent.
Athimalaipet Ramanan
Connection Strength
0.215
Adolescent
  1. Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children. Indian Pediatr. 2020 11 15; 57(11):1010-1014.
    View in: PubMed
    Score: 0.025
  2. Hyperinflammatory Syndrome in Children Associated With COVID-19: Need for Awareness. Indian Pediatr. 2020 Oct 15; 57(10):929-935.
    View in: PubMed
    Score: 0.025
  3. Coronavirus Disease 2019 (COVID-19) in Children - What We Know So Far and What We Do Not. Indian Pediatr. 2020 05 15; 57(5):435-442.
    View in: PubMed
    Score: 0.024
  4. Same but different? A thematic analysis on adalimumab biosimilar switching among patients with juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2019 Oct 04; 17(1):67.
    View in: PubMed
    Score: 0.023
  5. Chronic non bacterial osteitis- a multicentre study. Pediatr Rheumatol Online J. 2018 Nov 22; 16(1):74.
    View in: PubMed
    Score: 0.022
  6. Magnetic resonance imaging of sacroiliitis in children: frequency of findings and interobserver reliability. Pediatr Radiol. 2018 10; 48(11):1621-1628.
    View in: PubMed
    Score: 0.021
  7. Cross sectional, qualitative thematic analysis of patient perspectives of disease impact in juvenile idiopathic arthritis-associated uveitis. Pediatr Rheumatol Online J. 2017 Aug 04; 15(1):58.
    View in: PubMed
    Score: 0.020
  8. Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis. N Engl J Med. 2017 04 27; 376(17):1637-1646.
    View in: PubMed
    Score: 0.020
  9. Cardiac involvement as a presenting feature of eosinophilic granulomatosis with polyangiitis in childhood. Clin Exp Rheumatol. 2017 Mar-Apr; 35 Suppl 103(1):225.
    View in: PubMed
    Score: 0.019
  10. Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials. Ann Rheum Dis. 2018 12; 77(12):1710-1719.
    View in: PubMed
    Score: 0.005
  11. Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy. Pediatr Rheumatol Online J. 2018 Aug 06; 16(1):51.
    View in: PubMed
    Score: 0.005
  12. Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series. Am J Ophthalmol. 2018 03; 187:158-166.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.